The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis - Concepedia

Concepedia

Publication | Open Access

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

DOI Full Paper Access

176

Citations

33

References

2015

Year

Maarten Van Roy, Cedric Ververken, Els Beirnaert, Sven Hoefman, Joost A. Kolkman, Michel Vierboom, Elia Breedveld, Bert ’t Hart, Sofie Poelmans, Lieselot Bontinck,

Arthritis Research & Therapy

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseMedicineRheumatic DiseasesImmunologyClinical DevelopmentPreclinical PharmacologyInflammatory Rheumatic DiseasePharmacologyRheumatoid Arthritis

References

	Year	Citations

Page 1

Page 1